Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine versus mycophenolate sodium for extra-renal systemic lupus erythematosus flares
2008-008934-35Phase 3Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in systemic lupus erythematosus (SLE) comparing Azathioprine with Mycophenolate sodium (2 arms). Primary endpoints: Complete clinical response rate and Disease activity improvement by SLEDAI and BILAG. Started Apr 2009; status: completed.
02
Drugs
azathioprinemycophenolate sodium
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2008-008934-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008934-35.